Formulary

July 4, 2017

Anticoagulants

Parenteral Anticoagulants: The main use of anticoagulants is to prevent thrombus formation or extension of an existing thrombus in the slower-moving venous side of the circulation, […]
July 4, 2017

Antifibrinolytic Drugs and Haemostatics

Contraindications: In patients with acquired defective color vision, since this prohibits measuring one endpoint that should be followed as a measure of toxicity. In patients with subarachnoid hemorrhage. In patients with active intravascular clotting.
July 4, 2017

Antiplatlet Drugs

Antiplatelet drugs decrease platelet aggregation and may inhibit thrombus formation in the arterial circulation, where anticoagulants have little effect.
July 3, 2017

Angiotensin-Converting Enzyme Inhibitors

The class of drugs called angiotensin converting enzyme (ACE) inhibitors, as the class name suggests, reduces the activity of angiotensin converting enzyme. ACE converts angiotensin I […]
July 3, 2017

Sympathomimetics

My formulary,Sympathomimetics,Dobutamine,Inotropic ,Indications,Contraindications,Administration,Dose ,Dopamine,ISOPRENALINE,pheochromocytoma ,Vasoconstrictor ,Ephedrine,Noradrenaline,Cardiopulmonary ,Resuscitaction,Adrenaline,Epinephrine
July 3, 2017

Nitrates, Calcium Channel Blockers and Other Antianginal Drugs

My formulary,Nitrates,Calcium Channel,Blockers,Antianginal,Drugs,Glyceryl Trinitrate,Nitrates,Isosorbide Dinitrate:,Indications,Contraindications,Administration,Dose ,Isosorbide ,Mononitrate,Nifedipine,Amlodipine,Diltiazem,Nimodipine,Verapamil,Amlodipine ,Valsartan,Trimetazidine,Ivabradine,Pentoxifylline,Diosmin,Rutosides
July 3, 2017

Alpha-Adrenoceptor Blocking Drugs

Terazosin: Indications: indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). also indicated for the treatment of hypertension alone or in combination with other antihypertensive […]
July 3, 2017

Angiotensin-II Receptor Antagonist

The class of drugs called angiotensin receptor blockers (ARBs), as the class name suggests, are drugs that block the action of angiotensin. Specifically, ARBs prevent angiotensin […]
July 2, 2017

Centrally Acting Antihypertensive Drugs

Methyldopa: Indications: hypertension Contraindications: contraindicated in patients with active hepatic disease, such as acute hepatitis and active cirrhosis, with liver disorders previously associated with methyldopa therapy. […]
Centrally Acting Antihypertensive Drugs
This website uses cookies to improve your experience. By using this website you agree to our Cookie Policy.
Read more